Analyst Research: Catalyst Pharmaceutical Partners Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

2.90USD
24 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$2.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
227,802
52-wk High
$3.49
52-wk Low
$1.70

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - CATALYST PHARMACEUTICAL PARTNERS INC (CPRX-O) 5 Dec 2014 Thomson Reuters Stock Report 11 25.00
"The Economy Matters" Report for CPRX: the economy's impact on CPRX's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 2 Dec 2014 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for CPRX 30 Nov 2014 ValuEngine, Inc. 11 25.00
Catalyst Pharmaceutical Ptnrs 29 Nov 2014 S&P Capital IQ Quantitative Report 10 115.00
COMPSCRIPT INC (CPRX) - REPORT FOR ACTIVE TRADERS 28 Nov 2014 Pechala's Reports 1 25.00
COMPSCRIPT INC (CPRX) 12-months forecast 28 Nov 2014 Pechala's Reports 1 15.00
Catalyst Pharmaceutical Partners Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 28 Nov 2014 Reuters Investment Profile 12 20.00
Value Graph: CATALYST PHARMA -- CPRX 27 Nov 2014 Ford Investor Services, Inc. 1 12.00
CATALYST PHARMA (CPRX) Zacks Company Snapshot 14 Nov 2014 Zacks Investment Research Inc. 1 12.00
 
Name Age Since Current Position

Patrick McEnany

66 2006 Chairman of the Board, President, Chief Executive Officer

Alicia Grande

42 2011 Chief Financial Officer, Vice President, Treasurer

Steven Miller

52 2011 Chief Operating Officer, Chief Scientific Officer

David Muth

59 2014 Executive Vice President - Corporate Development

M. Douglas Winship

65 2006 Vice President - Regulatory Operations
Search Stocks